<DOC>
	<DOCNO>NCT01224769</DOCNO>
	<brief_summary>This retrospective study collect evaluate clinical experience reach Italy use bendamustine alone combine rituximab treatment patient relapse refractory chronic lymphoproliferative disorder .</brief_summary>
	<brief_title>Bendamustine Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>patient relapse refractory chronic lymphoproliferative disorder salvage treatment bendamustine +/ rituximab age â‰¥ 18 year previous treatment bendamustine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>